Diabetes lecture 2 Flashcards
Biguanide
Metformin
SGLT2 inhibitors
Canagliflozin
Dapagliflozin
Empagliflozin
GLP-1 receptor agonist
Exenatide
Liraglutide
Dulaglutide
Semaglutide (Ozempic (Sc) and Rybelsus (PO)
Sulfonylureas
Glyburide
Glipizide
Non-SU secretagogues
Repaglinide
DPP4 inhibitors
Sitagliptin
Saxagliptan
Linagliptin
TZDs
Pioglitazone
Metformin MOA
decreases hepatic glucose output, lowing fasting BG levels
enhances insulin sensitivity of both hepatic and muscle tissue
Metformin efficacy
lowers A1C 1-1.5%
weight loss
does not cause hypoglycemia
Metformin ADE
GI –> diarrhea, cramping, bloating
ER formulation –> less GI effects
Vitamin B 12 deficiency
Lactic acidosis -rare
Metformin (when to not use)
known hypersensitivity
surgical procedures
alcohol abuse
liver dysfunction
Significant renal disease
iodinated contrast media (GFR < 60)
Metformin and renal insufficiency
GFR > 60 –> ok
GFR 45-59 –> ok
GFR 30-44 –> metformin shouldn’t be started but can be continued
GFR < 30 –> do not use
Metformin dosing
usual dose is 1000 mg BID
500 or 850 mg po daily (with largest meal)
500mg po BID (with two largest meals)
if no GI effects, increase every 1-2 wks to max dose of 2000-25500mg/day
Metformin ER
given once daily
500, 750, 1000 ER tabs
titrate to 2000mg/daily
if taking 750 tab, max dose is 1500mg/day
Metformin monitoring
Counsel on adherence
A1c, renal function, vit B12
SMBG readings
take with meals